Item 8.01 Other Events.
On November 24, 2021, Supernus Pharmaceuticals, Inc. (the "Company") issued a
press release regarding a recent ransomware incident. The incident had no
significant impact on the Company's business and did not cause any serious
disruption to the Company's operations. A copy of the press release is filed as
Exhibit 99.1 hereto, and the text of such press release is incorporated herein
by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit Description
99.1 Press Release dated November 24, 2021.
104 Cover Page Interactive Data File (the cover page XBRL tags are embedded
within the Inline XBRL document).
© Edgar Online, source Glimpses